Using PrEP, Doing It for Ourselves

Abroad (travel likely)Recruiting

Conditions

HIV Prevention · PrEP

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Duke University School of Nursing, Durham, North Carolina, United States
Contact: Study coordinator (Niasha Fray, MA, MSPH) · niasha.fray@duke.edu · 9196688325
Contact: Principal Investigator (Schenita Randolph, PhD, MPH, RN, FAAN)
Ragan Johnson, DNP, FNP-BC, CNE, FAANP (Sub-investigator)
Michael Relf, PhD, RN, ANEF, FAAN (Sub-investigator)
Hannah Lane, PhD (Sub-investigator)

Study leads

Schenita Randolph, PhD
Principal Investigator
Duke University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PathToScale: The PERSIST Trial

Oral Pre-exposure Prophylaxis (PrEP) · Long-acting Injectable Cabotegravir for PrEP

Abroad (travel likely)Recruiting

Lilongwe, Malawi

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

HIV · Hematologic Malignancies

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

HIV · Prophylaxis · Injectable

Abroad (travel likely)RecruitingPHASE1

Baltimore, United States

Home-based Self-sampling for Cervical Cancer Prevention Education Intervention in Ghana

Cervical Cancer Screening · HIV · Self-sampling

Abroad (travel likely)Recruiting

Cape Coast, Ghana